We value your privacy

We use cookies to analyze site usage and improve your experience. You can accept all, reject non-essential, or customize. See our Privacy Policy.

HRT · Special situations

HRT for women with endometriosis

Endometriosis can recur or reactivate on estrogen therapy. Combined estrogen-progestogen HRT (even in women without a uterus after hysterectomy for endometriosis) reduces reactivation risk compared with estrogen alone.

Written by the Kindr Health Editorial & Clinical TeamMedically reviewed by Kindr Health Clinical Team NPI 1609792902Published Last reviewed

Regimen considerations

  • Combined continuous estrogen + progestogen preferred
  • Lowest effective estradiol dose
  • Monitor for pelvic pain recurrence

Frequently asked questions

Can I use HRT if I have endometriosis?

Yes. The benefits of HRT after early menopause usually outweigh reactivation risk with proper regimen choice.

Estrogen-only or combined?

Combined estrogen + progestogen is preferred even post-hysterectomy in this group.

What about tibolone?

An option in some countries; discuss with your clinician.

Considering a physician-supervised longevity protocol? Kindr Health evaluates peptide therapy as part of personalized perimenopause and menopause care.

Request your Longevity Consult →

Explore Kindr Health

HRT Hub →
Estrogen, progesterone, testosterone protocols
34 Symptoms →
The complete symptom index
Care Near Me →
Find menopause care in your city
Browse by State →
Licensed clinicians in all 50 states
Kindr Journal →
Evidence-based menopause reporting
Editorial Team →
Who reviews Kindr clinical content

Related: FDA peptide review July 2026 briefing · Peptide therapy hub · Longevity service

Written and medically reviewed by the Kindr Health Clinical Team · Published 2026-06-19 · Last reviewed 2026-07-01. Compounded medications are prepared by FDA-registered 503A pharmacies and are not FDA-approved drug products.